Next Article in Journal
Lipid Profile Characterization of Human Micro-Fragmented Adipose Tissue via Untargeted Lipidomics
Previous Article in Journal
A Hybrid Sequential Feature Selection Approach for Identifying New Potential mRNA Biomarkers for Usher Syndrome Using Machine Learning
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation

by
Daria A. Chiglintseva
,
Olga A. Patutina
* and
Marina A. Zenkova
Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia
*
Author to whom correspondence should be addressed.
Biomolecules 2025, 15(7), 965; https://doi.org/10.3390/biom15070965
Submission received: 21 May 2025 / Revised: 24 June 2025 / Accepted: 2 July 2025 / Published: 4 July 2025
(This article belongs to the Section Biomacromolecules: Proteins, Nucleic Acids and Carbohydrates)

Abstract

The selective regulation of gene expression at the RNA level represents a rapidly evolving field offering substantial clinical potential. This review examines the molecular mechanisms of intracellular enzymatic systems that utilize single-stranded nucleic acids to downregulate specific RNA targets. The analysis encompasses antisense oligonucleotides and synthetic mimics of small interfering RNA (siRNA), microRNA (miRNA), transfer RNA-derived small RNA (tsRNA), and PIWI-interacting RNA (piRNA), elucidating their intricate interactions with crucial cellular machinery, specifically RNase H1, RNase P, AGO, and PIWI proteins, mediating their biological effects. The functional and structural characteristics of these endonucleases are examined in relation to their mechanisms of action and resultant therapeutic outcomes. This comprehensive analysis illuminates the interactions between single-stranded nucleic acids and their endonuclease partners, covering antisense inhibition pathways as well as RNA interference processes. This field of research has important implications for advancing targeted RNA modulation strategies across various disease contexts.
Keywords: RNA-targeted therapy; RNase H1; RNase P; AGO2; antisense oligonucleotide; EGS; siRNA; miRNA; tsRNA; piRNA RNA-targeted therapy; RNase H1; RNase P; AGO2; antisense oligonucleotide; EGS; siRNA; miRNA; tsRNA; piRNA
Graphical Abstract

Share and Cite

MDPI and ACS Style

Chiglintseva, D.A.; Patutina, O.A.; Zenkova, M.A. Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation. Biomolecules 2025, 15, 965. https://doi.org/10.3390/biom15070965

AMA Style

Chiglintseva DA, Patutina OA, Zenkova MA. Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation. Biomolecules. 2025; 15(7):965. https://doi.org/10.3390/biom15070965

Chicago/Turabian Style

Chiglintseva, Daria A., Olga A. Patutina, and Marina A. Zenkova. 2025. "Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation" Biomolecules 15, no. 7: 965. https://doi.org/10.3390/biom15070965

APA Style

Chiglintseva, D. A., Patutina, O. A., & Zenkova, M. A. (2025). Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation. Biomolecules, 15(7), 965. https://doi.org/10.3390/biom15070965

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop